Related Experiment Video
Updated: Jun 5, 2025

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
Published on: March 16, 2018
Impact of repeated intranasal gentamicin irrigation on auditory brainstem evoked potentials in rats
Yusra Mansour1, LeAnn Haddad2, Zachary Breeden2
1Department of Otolaryngology - Head and Neck Surgery, Henry Ford Macomb Hospital, Clinton Township, MI, USA.
Abstract:
Gentamicin is a bactericidal aminoglycoside antibiotic that broadly targets Gram-negative microbes. Both human and animal studies have shown that administration of gentamicin is ototoxic by several routes of administration and results in sensorineural hearing loss due to damaged hair cell at the base of the cochlea. However, gentamicin is also administered intranasally to treat sinusitis in humans, but no animal studies have examined ototoxicity of gentamicin administered via this route. We hypothesized that intranasal irrigation of gentamicin will result in ototoxicity and impaired auditory function similar to systemic delivery. We investigated this hypothesis in Sprague-Dawley rats that received intranasal irrigations of gentamicin or saline from postnatal day (P) 21-31. We examined auditory function by assessing brainstem auditory evoked potentials in response to both broadband clicks and pure tone-pips (4, 8, 16, 24 and 32 kHz) on P41. We found significant changes in auditory function in gentamicin-exposed animals. Specifically, gentamicin-exposed animals had significantly higher thresholds in response to both clicks and tone-pips. In response to broadband clicks, there were no changes in latency for waves I through IV. However, we found significantly longer wave and interwave latencies for all waves in response to the 24 kHz tone-pip. Together, these findings suggest that intranasal administration of gentamicin results in impaired auditory function consistent with other routes of delivery.
Insights
Intranasal gentamicin, used for sinusitis, causes hearing loss in rats similar to other administration methods. This study reveals ototoxicity from nasal gentamicin, impacting auditory function and hair cells.
Area of Science:
- Ototoxicology
- Neuroscience
- Pharmacology
Background:
- Gentamicin is a bactericidal antibiotic effective against Gram-negative bacteria.
- Systemic gentamicin administration is known to cause ototoxicity, leading to sensorineural hearing loss.
- Intranasal gentamicin is used to treat sinusitis in humans, but its ototoxicity via this route is unstudied.
Purpose of the Study:
- To investigate the ototoxicity of intranasal gentamicin administration in Sprague-Dawley rats.
- To determine if intranasal gentamicin impairs auditory function similarly to systemic delivery.
Main Methods:
- Sprague-Dawley rats received daily intranasal gentamicin or saline irrigations from postnatal day 21 to 31.
- Auditory function was assessed on postnatal day 41 using brainstem auditory evoked potentials (BAEPs).
- BAEPs were measured in response to broadband clicks and pure tone-pips at frequencies of 4, 8, 16, 24, and 32 kHz.
Main Results:
- Gentamicin-exposed rats exhibited significantly higher auditory thresholds for both clicks and pure tone-pips.
- No significant changes in wave I-IV latency were observed for broadband clicks.
- Significant increases in wave and interwave latencies occurred for the 24 kHz tone-pip in gentamicin-exposed rats.
Conclusions:
- Intranasal administration of gentamicin leads to impaired auditory function in rats.
- The ototoxic effects observed are consistent with those seen from other routes of gentamicin delivery.
- Further research is warranted to understand the clinical implications of intranasal gentamicin use.
More Related Videos
09:06Cochlear Implant Surgery and Electrically-evoked Auditory Brainstem Response Recordings in C57BL/6 Mice
Published on: January 9, 2019
12:21The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration
Published on: November 26, 2015